×
About 54,674 results

ALLMedicine™ Systemic Lupus Erythematosus Center

Research & Reviews  25,953 results

Two shared immune cell signatures stratify patients with Sjögren's syndrome and systemi...
https://doi.org/10.1002/art.41708
Arthritis & Rheumatology (Hoboken, N.J.); Martin-Gutierrez L, Peng J et. al.

Mar 1st, 2021 - Similarities in the clinical and laboratory features of patients with primary Sjögren's syndrome (pSS) and systemic lupus erythematosus (SLE) have led to attempts to treat pSS and SLE patients with similar biologic therapeutics. However, the resul...

Medication adherence of patients with Systemic Lupus Erythematosus and Rheumatoid Arthr...
https://doi.org/10.2174/1573397117666210301144651
Current Rheumatology Reviews; Shenavandeh S, Mani A et. al.

Mar 1st, 2021 - In systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), due to their long term, multi-drug exposure and their side effects, non-adherence to therapy is common and is associated with adverse clinical outcome. In this study, we aimed to...

Pneumocystis jirovecii pneumonia in systemic lupus erythematosus: a nationwide cohort s...
https://doi.org/10.1002/acr.24584
Arthritis Care & Research; Wang WH, Lai CC et. al.

Mar 1st, 2021 - To evaluate PJP infection risk in patients with SLE in Taiwan. We identified 24,367 patients with SLE from the National Health Insurance research database between 1997 and 2012 and compared the PJP incidence rates (IRs) with those in 243,670 age- ...

Hearing loss in patients with systemic lupus erythematosus: A systematic review and met...
https://doi.org/10.1177/0961203321997919
Lupus Yuen E, Fried J et. al.

Mar 1st, 2021 - To determine the prevalence of hearing loss (HL) in patients with systemic lupus erythematosus (SLE), describe frequency-specific hearing threshold changes in this patient population as compared to age-matched control, and compare the clinical and...

Elevated soluble Tim-3 correlates with disease activity of systemic lupus erythematosus.
https://doi.org/10.1080/08916934.2021.1891535
Autoimmunity Zhao D, Li C et. al.

Mar 1st, 2021 - T cell immunoglobulin and mucin domain-containing molecule-3(Tim-3) has been found to play important roles in systemic lupus erythematosus (SLE), but whether sTim-3 is involved in the development of SLE remains unknown. In this study, we firstly o...

see more →

Guidelines  87 results

ACR Convergence 2020: Study Data for Lupus & Rheumatoid Arthritis
https://www.the-rheumatologist.org/article/acr-convergence-2020-study-data-for-lupus-rheumatoid-arthritis/
The Rheumatologist; Hickman RJ.

Nov 8th, 2020 - At the annual meeting’s second Plenary Session, Saturday, Nov. 7, speakers highlighted phase 2 results of a potential new biologic for systemic lupus erythematosus (SLE), as well as data on remission maintenance in rheumatoid arthritis (RA) after ...

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
https://pubmed.ncbi.nlm.nih.gov/33154498/
Scientific Reports; Cohen IV, Makunts T et. al.

Nov 4th, 2020 - Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization's List of Essential Medications for treating non-resistant malaria, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In addition, both drugs are cu...

Do Menopause and Aging Affect the Onset and Progression of Rheumatoid Arthritis and Systemic Lupus Erythematosus?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557711/
Cureus Shah L

Oct 11th, 2020 - Rheumatoid arthritis and systemic lupus erythematosus (SLE) are autoimmune diseases that are commonly seen in the female population. Rheumatoid arthritis mainly consists of distal symmetrical deforming polyarthritis. SLE patients have immune compl...

Fasting Triglycerides & Glucose Index: A Useful Screening Test for Assessing Insulin Resistance in Patients Diagnosed with Rheumatoid Arthritis & Systemic Lupus Erythematosus
https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-019-0495-x
Diabetology & Metabolic Syndrome; Contreras-Haro B,et al

Nov 26th, 2019 - Insulin resistance (IR) is frequently observed in patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). In clinical practice, IR assessment is limited to a low proportion of patients due to cost and equipment and technical...

Sjögren’s Syndrome in Systemic Lupus Erythematosus - a Subset Characterized by a Systemic Inflammatory State
http://www.jrheum.org/content/early/2019/09/11/jrheum.190250
J Rheumatology; Ruacho G,et al

Sep 20th, 2019 - Secondary Sjögren’s syndrome (SLE-sSS) is an often-neglected subset of patients with Systemic lupus erythematosus (SLE). Furthermore, primary Sjögren’s syndrome overlaps and can be difficult to delineate from SLE. To shed light on the SLE-sSS subs...

see more →

Drugs  27 results see all →

Clinicaltrials.gov  26,917 results

Two shared immune cell signatures stratify patients with Sjögren's syndrome and systemi...
https://doi.org/10.1002/art.41708
Arthritis & Rheumatology (Hoboken, N.J.); Martin-Gutierrez L, Peng J et. al.

Mar 1st, 2021 - Similarities in the clinical and laboratory features of patients with primary Sjögren's syndrome (pSS) and systemic lupus erythematosus (SLE) have led to attempts to treat pSS and SLE patients with similar biologic therapeutics. However, the resul...

Medication adherence of patients with Systemic Lupus Erythematosus and Rheumatoid Arthr...
https://doi.org/10.2174/1573397117666210301144651
Current Rheumatology Reviews; Shenavandeh S, Mani A et. al.

Mar 1st, 2021 - In systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), due to their long term, multi-drug exposure and their side effects, non-adherence to therapy is common and is associated with adverse clinical outcome. In this study, we aimed to...

Pneumocystis jirovecii pneumonia in systemic lupus erythematosus: a nationwide cohort s...
https://doi.org/10.1002/acr.24584
Arthritis Care & Research; Wang WH, Lai CC et. al.

Mar 1st, 2021 - To evaluate PJP infection risk in patients with SLE in Taiwan. We identified 24,367 patients with SLE from the National Health Insurance research database between 1997 and 2012 and compared the PJP incidence rates (IRs) with those in 243,670 age- ...

Hearing loss in patients with systemic lupus erythematosus: A systematic review and met...
https://doi.org/10.1177/0961203321997919
Lupus Yuen E, Fried J et. al.

Mar 1st, 2021 - To determine the prevalence of hearing loss (HL) in patients with systemic lupus erythematosus (SLE), describe frequency-specific hearing threshold changes in this patient population as compared to age-matched control, and compare the clinical and...

Elevated soluble Tim-3 correlates with disease activity of systemic lupus erythematosus.
https://doi.org/10.1080/08916934.2021.1891535
Autoimmunity Zhao D, Li C et. al.

Mar 1st, 2021 - T cell immunoglobulin and mucin domain-containing molecule-3(Tim-3) has been found to play important roles in systemic lupus erythematosus (SLE), but whether sTim-3 is involved in the development of SLE remains unknown. In this study, we firstly o...

see more →

News  1,675 results

New Tool to Aid Accurate Lupus Diagnosis
https://www.medscape.com/viewarticle/946540

Feb 28th, 2021 - NEW YORK (Reuters Health) - Clinicians in Greece have developed and validated a simple and accurate tool to aid diagnosis of systemic lupus erythematosus (SLE) based on standard clinical and serological features. "SLE diagnosis often poses signifi...

Meta-Analysis Finds Much Less Lupus Than Expected
https://www.medscape.com/viewarticle/945116

Feb 1st, 2021 - The prevalence of systemic lupus erythematosus (SLE) appears to be much lower than previously believed and may pose "a potential risk to research funding for the disease," according to results of a meta-analysis involving a network of population-b...

High Hydroxychloroquine Blood Level May Lower Thrombosis Risk in Lupus
https://www.medscape.com/viewarticle/943726

Jan 6th, 2021 - Maintaining an average hydroxychloroquine whole blood level above 1,068 ng/mL significantly reduced the risk of thrombosis in adults with systemic lupus erythematosus, based on data from 739 patients. Hydroxychloroquine (HCQ) is a common treatment...

FDA Expands Belimumab Indication to Adults With Lupus Nephritis
https://www.medscape.com/viewarticle/942894

Dec 17th, 2020 - The US Food and Drug Administration (FDA) has expanded the indication for belimumab (Benlysta) to adults with active lupus nephritis who are receiving standard therapy. Roughly 40% of patients with systemic lupus erythematosus (SLE) develop lupus ...

High-Need, High-Cost Lupus Patients Described for First Time
https://www.medscape.com/viewarticle/942712

Dec 15th, 2020 - A small group of patients with systemic lupus erythematosus (SLE) who have high costs and needs and frequent hospitalizations can be identified through a shared set of sociodemographic characteristics and risk factors that distinguish them from ot...

see more →

Patient Education  15 results see all →